Safety Reporting

Current section refers to the item 4.11 Safety Reporting of the INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2). It provides an overview of requirements for reporting of Serious Adverse Events occurring during a clinical trial.

 

4.11.1 All serious adverse events (SAEs) should be reported immediately to the sponsor except for those SAEs that the protocol or other document (e.g., Investigator's Brochure) identifies as not needing immediate reporting. The immediate reports should be followed promptly by detailed, written reports.

The immediate and follow-up reports should identify subjects by unique code numbers assigned to the trial subjects rather than by the subjects' names, personal identification numbers, and/or addresses.

The investigator should also comply with the applicable regulatory requirement(s) related to the reporting of unexpected serious adverse drug reactions to the regulatory authority(ies) and the IRB/IEC.

4.11.2 Adverse events and/or laboratory abnormalities identified in the protocol as critical to safety evaluations should be reported to the sponsor according to the reporting requirements and within the time periods specified by the sponsor in the protocol.

4.11.3 For reported deaths, the investigator should supply the sponsor and the IRB/IEC with any additional requested information (e.g., autopsy reports and terminal medical reports).

Clinical Research News

Can a Blood Test Safely Screen for Ovarian Cancer in Women at Average Risk?
No Invasive Breast Cancer Found After Surgery — but Tumor DNA Is Detectable. Should Treatment Intensify?
After a Heart Attack or Stent, Do Older Adults Need Lifelong Aspirin?
Could One Radiation Treatment Let Some Patients With Small Breast Cancer Avoid Lumpectomy?
Could a Monthly Shot Help Maintain Weight Loss After Wegovy or Zepbound?
Not another GLP-1: petrelintide moves into a 3,900-person Phase III obesity trial
Can varicose veins be treated without needles, catheters or heat? First-in-human study tests non-thermal focused ultrasound

即将进行的临床试验

Clinical Research Jobs

More jobs

赞助者和合作者

医疗条件

药物干预

订阅